{"slug":"platinum","tag":"platinum","variants":["platinum"],"description":"No description yet","count":1,"kinds":{"trial":1},"related":[{"slug":"breast","tag":"breast","shared":1},{"slug":"uk","tag":"uk","shared":1}],"records":[{"id":"tnt","kind":"trial","name":"TNT (Triple Negative Trial)","route":"/trials/tnt/","status":"mixed","tldr":"The UK phase 3 trial that showed carboplatin is not better than docetaxel for triple-negative breast cancer as a whole, but is for the germline BRCA1/2 subgroup, and that gave the NHS its evidence for platinum in BRCA carriers."}]}